HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Plasma DNA integrity indicates response to neoadjuvant chemotherapy in patients with locally confined breast cancer.

AuthorsJulia Lehner, Oliver J Stötzer, Debora M I Fersching, Dorothea Nagel, Stefan Holdenrieder
JournalInternational journal of clinical pharmacology and therapeutics (Int J Clin Pharmacol Ther) Vol. 51 Issue 1 Pg. 59-62 (Jan 2013) ISSN: 0946-1965 [Print] Germany
PMID23260002 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents
  • Biomarkers, Tumor
  • Taxoids
  • Docetaxel
  • Epirubicin
  • Cyclophosphamide
  • DNA
Topics
  • Antineoplastic Agents (blood, therapeutic use)
  • Biomarkers, Tumor (blood)
  • Breast Neoplasms (blood, drug therapy, surgery)
  • Carcinoma, Ductal, Breast (blood, drug therapy, surgery)
  • Carcinoma, Lobular (blood, drug therapy, surgery)
  • Cyclophosphamide (blood, therapeutic use)
  • DNA (blood)
  • Docetaxel
  • Epirubicin (blood, therapeutic use)
  • Female
  • Follow-Up Studies
  • Humans
  • Neoadjuvant Therapy (methods)
  • Taxoids (blood, therapeutic use)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: